STABL — Stayble Therapeutics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK17.06m
- SEK14.10m
Annual cashflow statement for Stayble Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | Interim Report | ARS | Interim Report | ARS | |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -15.5 | -12.1 | -24.5 | -23.7 | — |
| Non-Cash Items | — | -0.078 | — | 0.193 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.66 | 2.54 | -0.095 | 0.007 | — |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -24.1 | -9.63 | -24.6 | -23.5 | — |
| Capital Expenditures | — | -0.001 | — | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.001 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.001 | 0.001 | 0 | — |
| Financing Cash Flow Items | -3.81 | -5.19 | 0 | -6.85 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31.2 | 36.2 | 0 | 25 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.04 | 26.6 | -24.6 | 1.23 | — |